Detalhe da pesquisa
1.
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Lancet Oncol
; 24(5): 443-456, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142371
2.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953525
3.
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(4): 501-513, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279270
4.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355464
5.
Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.
BMC Cancer
; 14: 977, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519703
6.
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
Future Oncol
; 10(2): 219-31, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24490608
7.
A Systematic Review of Population-Based Studies of Chronic Bowel Symptoms in Cancer Survivors following Pelvic Radiotherapy.
Cancers (Basel)
; 15(16)2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627064
8.
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial [version 2; peer review: 2 approved].
NIHR Open Res
; 2: 49, 2023 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035713
9.
ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK.
Clin Colorectal Cancer
; 18(4): 280-291.e5, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31451367
10.
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol.
BMJ Open
; 9(12): e034708, 2019 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857319
11.
Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non-castration-resistant prostate cancer.
Urol Oncol
; 33(8): 337.e1-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26092557
12.
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
Eur Urol
; 66(1): 32-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24054872
13.
Transperineal interstitial permanent prostate brachytherapy for carcinoma of the prostate.
Surg Oncol
; 11(1-2): 25-34, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12031865